Clinical trial enrollment of adolescents and young adults with sarcoma

Lara E. Davis; Katherine A. Janeway; Aaron R. Weiss; Yen Lin E. Chen; Thomas J. Scharschmidt; Mark Krailo; Julia L. Glade Bender; Lisa M. Kopp; Shreyaskumar R. Patel; Gary K. Schwartz; L. Elise Horvath; Douglas S. Hawkins; Meredith K. Chuk; Denise K. Reinke; Richard G. Gorlick; R. Lor Randall

doi:10.1002/cncr.30757

Clinical trial enrollment of adolescents and young adults with sarcoma

Lara E. Davis, Katherine A. Janeway, Aaron R. Weiss, Yen Lin E. Chen, Thomas J. Scharschmidt, Mark Krailo, Julia L. Glade Bender, Lisa M. Kopp, Shreyaskumar R. Patel, Gary K. Schwartz, L. Elise Horvath, Douglas S. Hawkins, Meredith K. Chuk, Denise K. Reinke, Richard G. Gorlick, R. Lor Randall

Knight Cancer Institute

Research output: Contribution to journal › Comment/debate

16 Scopus citations

Abstract

More than half of all sarcomas occur in adolescents and young adults (AYAs) aged 15 to 39 years. After the publication of the AYA series in the April 1, 2016 issue of Cancer, several leaders in the field of sarcoma across disciplines gathered to discuss the status of sarcoma clinical research in AYAs. They determined that a focused effort to include the underrepresented and understudied AYA population in current and future sarcoma clinical trials is overdue. Trial enrichment for AYA-aged sarcoma patients will produce more meaningful results that better represent the disease's biology, epidemiology, and treatment environment. To address the current deficit, this commentary outlines changes believed to be necessary to expediently achieve an increase in the enrollment of AYAs in sarcoma clinical trials. Cancer 2017;123:3434-40.

Original language	English (US)
Pages (from-to)	3434-3440
Number of pages	7
Journal	Cancer
Volume	123
Issue number	18
DOIs	https://doi.org/10.1002/cncr.30757
State	Published - Sep 15 2017

Keywords

National Clinical Trials Network
adolescent
clinical trials
sarcoma
young adult

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/cncr.30757

Fingerprint Dive into the research topics of 'Clinical trial enrollment of adolescents and young adults with sarcoma'. Together they form a unique fingerprint.

Cite this

Davis, L. E., Janeway, K. A., Weiss, A. R., Chen, Y. L. E., Scharschmidt, T. J., Krailo, M., Glade Bender, J. L., Kopp, L. M., Patel, S. R., Schwartz, G. K., Horvath, L. E., Hawkins, D. S., Chuk, M. K., Reinke, D. K., Gorlick, R. G., & Randall, R. L. (2017). Clinical trial enrollment of adolescents and young adults with sarcoma. Cancer, 123(18), 3434-3440. https://doi.org/10.1002/cncr.30757

Clinical trial enrollment of adolescents and young adults with sarcoma. / Davis, Lara E.; Janeway, Katherine A.; Weiss, Aaron R.; Chen, Yen Lin E.; Scharschmidt, Thomas J.; Krailo, Mark; Glade Bender, Julia L.; Kopp, Lisa M.; Patel, Shreyaskumar R.; Schwartz, Gary K.; Horvath, L. Elise; Hawkins, Douglas S.; Chuk, Meredith K.; Reinke, Denise K.; Gorlick, Richard G.; Randall, R. Lor.

In: Cancer, Vol. 123, No. 18, 15.09.2017, p. 3434-3440.

Research output: Contribution to journal › Comment/debate

Davis, Lara E. ; Janeway, Katherine A. ; Weiss, Aaron R. ; Chen, Yen Lin E. ; Scharschmidt, Thomas J. ; Krailo, Mark ; Glade Bender, Julia L. ; Kopp, Lisa M. ; Patel, Shreyaskumar R. ; Schwartz, Gary K. ; Horvath, L. Elise ; Hawkins, Douglas S. ; Chuk, Meredith K. ; Reinke, Denise K. ; Gorlick, Richard G. ; Randall, R. Lor. / Clinical trial enrollment of adolescents and young adults with sarcoma. In: Cancer. 2017 ; Vol. 123, No. 18. pp. 3434-3440.

@article{c8f945e607f544e1a2a94623771ea056,

title = "Clinical trial enrollment of adolescents and young adults with sarcoma",

abstract = "More than half of all sarcomas occur in adolescents and young adults (AYAs) aged 15 to 39 years. After the publication of the AYA series in the April 1, 2016 issue of Cancer, several leaders in the field of sarcoma across disciplines gathered to discuss the status of sarcoma clinical research in AYAs. They determined that a focused effort to include the underrepresented and understudied AYA population in current and future sarcoma clinical trials is overdue. Trial enrichment for AYA-aged sarcoma patients will produce more meaningful results that better represent the disease's biology, epidemiology, and treatment environment. To address the current deficit, this commentary outlines changes believed to be necessary to expediently achieve an increase in the enrollment of AYAs in sarcoma clinical trials. Cancer 2017;123:3434-40.",

keywords = "National Clinical Trials Network, adolescent, clinical trials, sarcoma, young adult",

author = "Davis, {Lara E.} and Janeway, {Katherine A.} and Weiss, {Aaron R.} and Chen, {Yen Lin E.} and Scharschmidt, {Thomas J.} and Mark Krailo and {Glade Bender}, {Julia L.} and Kopp, {Lisa M.} and Patel, {Shreyaskumar R.} and Schwartz, {Gary K.} and Horvath, {L. Elise} and Hawkins, {Douglas S.} and Chuk, {Meredith K.} and Reinke, {Denise K.} and Gorlick, {Richard G.} and Randall, {R. Lor}",

year = "2017",

month = sep,

day = "15",

doi = "10.1002/cncr.30757",

language = "English (US)",

volume = "123",

pages = "3434--3440",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "18",

}

TY - JOUR

T1 - Clinical trial enrollment of adolescents and young adults with sarcoma

AU - Davis, Lara E.

AU - Janeway, Katherine A.

AU - Weiss, Aaron R.

AU - Chen, Yen Lin E.

AU - Scharschmidt, Thomas J.

AU - Krailo, Mark

AU - Glade Bender, Julia L.

AU - Kopp, Lisa M.

AU - Patel, Shreyaskumar R.

AU - Schwartz, Gary K.

AU - Horvath, L. Elise

AU - Hawkins, Douglas S.

AU - Chuk, Meredith K.

AU - Reinke, Denise K.

AU - Gorlick, Richard G.

AU - Randall, R. Lor

PY - 2017/9/15

Y1 - 2017/9/15

N2 - More than half of all sarcomas occur in adolescents and young adults (AYAs) aged 15 to 39 years. After the publication of the AYA series in the April 1, 2016 issue of Cancer, several leaders in the field of sarcoma across disciplines gathered to discuss the status of sarcoma clinical research in AYAs. They determined that a focused effort to include the underrepresented and understudied AYA population in current and future sarcoma clinical trials is overdue. Trial enrichment for AYA-aged sarcoma patients will produce more meaningful results that better represent the disease's biology, epidemiology, and treatment environment. To address the current deficit, this commentary outlines changes believed to be necessary to expediently achieve an increase in the enrollment of AYAs in sarcoma clinical trials. Cancer 2017;123:3434-40.

AB - More than half of all sarcomas occur in adolescents and young adults (AYAs) aged 15 to 39 years. After the publication of the AYA series in the April 1, 2016 issue of Cancer, several leaders in the field of sarcoma across disciplines gathered to discuss the status of sarcoma clinical research in AYAs. They determined that a focused effort to include the underrepresented and understudied AYA population in current and future sarcoma clinical trials is overdue. Trial enrichment for AYA-aged sarcoma patients will produce more meaningful results that better represent the disease's biology, epidemiology, and treatment environment. To address the current deficit, this commentary outlines changes believed to be necessary to expediently achieve an increase in the enrollment of AYAs in sarcoma clinical trials. Cancer 2017;123:3434-40.

KW - National Clinical Trials Network

KW - adolescent

KW - clinical trials

KW - sarcoma

KW - young adult

UR - http://www.scopus.com/inward/record.url?scp=85028979707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028979707&partnerID=8YFLogxK

U2 - 10.1002/cncr.30757

DO - 10.1002/cncr.30757

M3 - Comment/debate

C2 - 28493547

AN - SCOPUS:85028979707

VL - 123

SP - 3434

EP - 3440

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 18

ER -